Reglan Medication Associated with Tardive Dyskinesia
What’s the problem?
Reglan (also known by the generic name metoclopramide) is prescribed to treat gastrointestinal disorders (GERD), acid reflux, nausea, and also used to increase milk production in nursing mothers. It is also used to treat slow gastric emptying in people with diabetes (also called diabetic gastroparesis), which can cause nausea, vomiting, heartburn, loss of appetite, and a feeling of fullness after meals.
It has recently been alleged that Reglan is associated with the serious movement disorder Tardive Dyskinesia. In January 2009, the FDA issued an alert warning against chronic use of metoclopramide-containing drugs and required a black box warning due to Reglan effects (which are often similar to Parkinson’s symptoms). Additionally, the manufacturers are now being required to implement a risk evaluation and mitigation strategy to ensure that patients are properly provided with information about the Reglan Tardive Dyskinesia problems. There have been a number of Reglan lawsuits filed based on the argument that the manufacturers failed to properly warn of the potential serious Tardive Dyskinesia symptoms that can develop after extended use of the drug.
Reglan Side Effects
The following is a list of birth defects associated with Reglan:
- involuntary/repetitive movements of the extremities
- facial tics
- lip smacking, pursing, and puckering
- facial grimacing
- tongue protrusion
- rapid eye movements or blinking
- impaired movements of the fingers
- Restless Leg Syndrome (RLS)